Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy

Published 2012 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
Authors
Keywords
Thyroid carcinomas, Cancer treatment, Cell cycle and cell division, Apoptosis, Cell cycle inhibitors, Chemotherapeutic agents, Cytotoxicity, Cyclins
Journal
PLoS One
Volume 7, Issue 10, Pages e46726
Publisher
Public Library of Science (PLoS)
Online
2012-10-16
DOI
10.1371/journal.pone.0046726

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.